References
[1] Phillips B, Morgan JE, Haeusler GM On behalf of the PICNICC Collaborative. Individual participant data validation of the PICNICC prediction model for febrile neutropenia. Archives of Disease in Childhood 2020;105:439-445 DOI:10.1136/archdischild-2019-317308
[2] Haeusler GM, Phillips R, Slavin MA, Babl FE, De Abreu Lourenco R, Mechinaud F, et al. Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia. EClinicalMedicine. DOI: 10.1016/j.eclinm.2020.100394
[3] Phillips, R., Sung, L., Amman, R. et al. Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis. Br J Cancer 2016:114;623–630 DOI: 10.1038/bjc.2016.28
[4] Phillips R, Hancock B, Graham J, Bromham N, Jin H, Berendse S. Prevention and management of neutropenic sepsis in patients with cancer: summary of NICE guidance. BMJ. 2012;345:e5368.
[5] Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, et al. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. J Clin Oncol. 2017;35(18):2082-94.